肾素–血管紧张素系统对慢性阻塞性肺疾病发展的影响
The Impact of the Renin-Angiotensin System on the Development of Chronic Obstructive Pulmonary Disease
摘要: 慢性阻塞性肺疾病是危害人类健康的常见病，反复发作的症状及进行性下降的肺功能大大降低了患者的生活质量。目前对COPD的治疗主要以缓解症状，减少急性发作为主，但难以延缓肺功能的减退，导致COPD的死亡率仍居高不下。近期研究发现肾素–血管紧张素系统(Ras)在肺组织局部高度表达，与多种肺疾病密切相关，血管紧张素转换酶抑制剂(ACEI)及血管紧张素-1型受体拮抗剂(ARB)的使用可减轻COPD的炎症反应，减少肺损伤，改善肺功能。因此，本文就RAS对COPD发展的影响做一综述。
Abstract: Chronic obstructive pulmonary disease (COPD) is a common disease that endangers human health. The recurrent symptoms and the progressively declining lung function have greatly reduced the quality of life of patients. At present, the treatment of COPD mainly focuses on relieving symptoms and reducing acute exacerbations, but it is difficult to delay the decline of lung function, resulting in the still high mortality rate of COPD. Recent studies have found that the renin-angiotensin system (RAS) is highly expressed in local lung tissues and is closely related to a variety of lung diseases. The use of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin type-1 receptor antagonists (ARB) can alleviate the inflammatory response of COPD, reduce lung injury and improve lung function. Therefore, this article reviews the impact of RAS on the development of COPD.
文章引用：曹森, 米洵宇, 潘均钧, 向志, 罗雪梅. 肾素–血管紧张素系统对慢性阻塞性肺疾病发展的影响[J]. 临床医学进展, 2025, 15(1): 1396-1403. https://doi.org/10.12677/acm.2025.151187

参考文献

[1] Chen, L.N. and Yang, X.H. (2013) Local Renin-Angiotensin System Disequilibrium and Acute Lung Injury. Progress in physiology, 44, 133-137.
[2] 张连霞, 赵慧霞, 于世杰, 等. 老年慢性阻塞性肺疾病病人中炎症因子、25-羟维生素D3水平变化及急性发作的相关危险因素[J]. 实用老年医学, 2020, 34(3): 250-253.
[3] 曹校校, 傅安安, 陈荣, 等. 血清高敏C-反应蛋白、肿瘤坏死因子-α联合肺功能检测在诊断慢性阻塞性肺疾病中的应用价值分析[J]. 中国卫生检验杂志, 2020, 30(3): 346-348, 351.
[4] Bouhnik, J., Galen, F.X., Menard, J., Corvol, P., Seyer, R., Fehrentz, J.A., et al. (1987) Production and Characterization of Human Renin Antibodies with Region-Oriented Synthetic Peptides. Journal of Biological Chemistry, 262, 2913-2918. [Google Scholar] [CrossRef] [PubMed]
[5] Mirabito Colafella, K.M., Bovée, D.M. and Danser, A.H.J. (2019) The Renin-Angiotensin-Aldosterone System and Its Therapeutic Targets. Experimental Eye Research, 186, Article 107680. [Google Scholar] [CrossRef] [PubMed]
[6] Cole-Jeffrey, C.T., Liu, M., Katovich, M.J., Raizada, M.K. and Shenoy, V. (2015) ACE2 and Microbiota: Emerging Targets for Cardiopulmonary Disease Therapy. Journal of Cardiovascular Pharmacology, 66, 540-550. [Google Scholar] [CrossRef] [PubMed]
[7] 向永红. 慢性间断性低氧大鼠氧化应激状态与RAS相关性研究及NAC干预作用[D]: [硕士学位论文]. 长沙: 中南大学, 2010.
[8] Vio, C.P., Salas, D., Cespedes, C., Diaz-Elizondo, J., Mendez, N., Alcayaga, J., et al. (2018) Imbalance in Renal Vasoactive Enzymes Induced by Mild Hypoxia: Angiotensin-Converting Enzyme Increases While Neutral Endopeptidase Decreases. Frontiers in Physiology, 9, Article 1791. [Google Scholar] [CrossRef] [PubMed]
[9] Zhang, R., Wu, Y., Zhao, M., Liu, C., Zhou, L., Shen, S., et al. (2009) Role of HIF-1α in the Regulation ACE and ACE2 Expression in Hypoxic Human Pulmonary Artery Smooth Muscle Cells. American Journal of Physiology-Lung Cellular and Molecular Physiology, 297, L631-L640. [Google Scholar] [CrossRef] [PubMed]
[10] Winklewski, P.J., Radkowski, M. and Demkow, U. (2016) Neuroinflammatory Mechanisms of Hypertension: Potential Therapeutic Implications. Current Opinion in Nephrology and Hypertension, 25, 410-416. [Google Scholar] [CrossRef] [PubMed]
[11] 叶剑滨, 林锦乐, 张文武. 血管紧张素II及其受体与急性呼吸窘迫综合征关系的研究进展[J]. 中华实用诊断与治疗杂志, 2017, 31(3): 310-312.
[12] Hong, S., Jung, H.I., Ahn, T.S., Kim, H., Lee, K., Baek, M., et al. (2017) Expressions and Clinical Significances of Angiopoietin-1, Angiopoietin-2, and Tie-2 Receptor in Patients with Colorectal Cancer. Annals of Coloproctology, 33, 9-15. [Google Scholar] [CrossRef] [PubMed]
[13] 孙会志, 孙海英, 李亚平. 脓毒症并发ARDS患者血清sTM、suPAR、Ang-2水平与炎症因子及预后的关系[J]. 检验医学与临床, 2022, 19(8): 1075-1079.
[14] 杨逢永, 房东东, 张柄涵, 等. 盐酸戊乙奎醚调控血管生成素2/血管内皮钙黏蛋白(Ang2/VE-Cadherin)通路减轻脂多糖诱导的大鼠肺损伤[J]. 细胞与分子免疫学杂志, 2023, 39(8): 708-713.
[15] Mei, D., Tan, W.S.D., Liao, W., Heng, C.K.M. and Wong, W.S.F. (2020) Activation of Angiotensin II Type-2 Receptor Protects against Cigarette Smoke-Induced COPD. Pharmacological Research, 161, Article 105223. [Google Scholar] [CrossRef] [PubMed]
[16] Sionov, R.V. and Haupt, Y. (1999) The Cellular Response to P53: The Decision between Life and Death. Oncogene, 18, 6145-6157. [Google Scholar] [CrossRef] [PubMed]
[17] 张建初, 熊先智, 辛建保, 等. P53蛋白调节血管紧张素Ⅱ诱导的内皮细胞凋亡[J]. 华中科技大学学报(医学版), 2002, 31(3): 280-283.
[18] Wang, R., Ibarra-Sunga, O., Verlinski, L., Pick, R. and Uhal, B.D. (2000) Abrogation of Bleomycin-Induced Epithelial Apoptosis and Lung Fibrosis by Captopril or by a Caspase Inhibitor. American Journal of Physiology-Lung Cellular and Molecular Physiology, 279, L143-L151. [Google Scholar] [CrossRef] [PubMed]
[19] Marshall, R.P., Gohlke, P., Chambers, R.C., Howell, D.C., Bottoms, S.E., Unger, T., et al. (2004) Angiotensin II and the Fibroproliferative Response to Acute Lung Injury. American Journal of Physiology-Lung Cellular and Molecular Physiology, 286, L156-L164. [Google Scholar] [CrossRef] [PubMed]
[20] Bullock, G.R., Steyaert, I., Bilbe, G., Carey, R.M., Kips, J., De Paepe, B., et al. (2001) Distribution of Type-1 and Type-2 Angiotensin Receptors in the Normal Human Lung and in Lungs from Patients with Chronic Obstructive Pulmonary Disease. Histochemistry and Cell Biology, 115, 117-124. [Google Scholar] [CrossRef] [PubMed]
[21] Shenoy, V., Ferreira, A.J., Qi, Y., Fraga-Silva, R.A., Díez-Freire, C., Dooies, A., et al. (2010) The Angiotensin-Converting Enzyme 2/Angiogenesis-(1-7)/Mas Axis Confers Cardiopulmonary Protection against Lung Fibrosis and Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine, 182, 1065-1072. [Google Scholar] [CrossRef] [PubMed]
[22] Xue, T., Wei, N., Xin, Z. and Qingyu, X. (2014) Angiotensin-Converting Enzyme-2 Overexpression Attenuates Inflammation in Rat Model of Chronic Obstructive Pulmonary Disease. Inhalation Toxicology, 26, 14-22. [Google Scholar] [CrossRef] [PubMed]
[23] Fang, Y., Gao, F. and Liu, Z. (2019) Angiotensin-Converting Enzyme 2 Attenuates Inflammatory Response and Oxidative Stress in Hyperoxic Lung Injury by Regulating NF-κB and Nrf2 Pathways. QJM: An International Journal of Medicine, 112, 914-924. [Google Scholar] [CrossRef] [PubMed]
[24] Gopallawa, I. and Uhal, B.D. (2014) Molecular and Cellular Mechanisms of the Inhibitory Effects of ACE-2/ANG1-7/Mas Axis on Lung Injury. Current Topics in Pharmacology, 18, 71-80.
[25] Gao, X., Xu, H., Zhang, B., Tao, T., Liu, Y., Xu, D., et al. (2019) Interaction of N‐Acetyl‐Seryl‐Aspartyl‐Lysyl‐Proline with the Angiotensin‐Converting Enzyme 2-Angiotensin‐(1-7)-Mas Axis Attenuates Pulmonary Fibrosis in Silicotic Rats. Experimental Physiology, 104, 1562-1574. [Google Scholar] [CrossRef] [PubMed]
[26] Shao, M., Wen, Z., Yang, H., Zhang, C., Xiong, J., Guan, X., et al. (2019) Exogenous Angiotensin (1-7) Directly Inhibits Epithelial-Mesenchymal Transformation Induced by Transforming Growth Factor-Β1 in Alveolar Epithelial Cells. Biomedicine & Pharmacotherapy, 117, Article 109193. [Google Scholar] [CrossRef] [PubMed]
[27] Liu, X., Yang, N., Tang, J., Liu, S., Luo, D., Duan, Q., et al. (2014) Downregulation of Angiotensin-Converting Enzyme 2 by the Neuraminidase Protein of Influenza a (H1N1) Virus. Virus Research, 185, 64-71. [Google Scholar] [CrossRef] [PubMed]
[28] Tejwani, V., Fawzy, A., Putcha, N., Castaldi, P.J., Cho, M.H., Pratte, K.A., et al. (2021) Emphysema Progression and Lung Function Decline among Angiotensin Converting Enzyme Inhibitors and Angiotensin-Receptor Blockade Users in the COPDGene Cohort. Chest, 160, 1245-1254. [Google Scholar] [CrossRef] [PubMed]
[29] Song, G., Ouyang, G. and Bao, S. (2005) The Activation of Akt/PKB Signaling Pathway and Cell Survival. Journal of Cellular and Molecular Medicine, 9, 59-71. [Google Scholar] [CrossRef] [PubMed]
[30] Del Fiorentino, A., Cianchetti, S., Celi, A., Dell’Omo, G. and Pedrinelli, R. (2009) The Effect of Angiotensin Receptor Blockers on C-Reactive Protein and Other Circulating Inflammatory Indices in Man. Vascular Health and Risk Management, 5, 233-242. [Google Scholar] [CrossRef] [PubMed]
[31] Zahradka, P., Werner, J.P., Buhay, S., Litchie, B., Helwer, G. and Thomas, S. (2002) NF-κB Activation Is Essential for Angiotensin II-Dependent Proliferation and Migration of Vascular Smooth Muscle Cells. Journal of Molecular and Cellular Cardiology, 34, 1609-1621. [Google Scholar] [CrossRef] [PubMed]
[32] 王均鹏, 包明威. 培哚普利对慢性阻塞性肺疾病大鼠肺组织PI3K及肺功能的影响[J]. 中国呼吸与危重监护杂志, 2015, 14(3): 260-263.
[33] 张萍, 邢琳琳, 阮昕, 等. 血管紧张素II受体拮抗剂对慢性阻塞性肺疾病大鼠炎症反应的抑制作用[J]. 中国老年学杂志, 2018, 38(14): 3474-3476.
[34] Kanazawa, H., Hirata, K. and Yoshikawa, J. (2003) Effects of Captopril Administration on Pulmonary Haemodynamics and Tissue Oxygenation during Exercise in ACE Gene Subtypes in Patients with COPD: A Preliminary Study. Thorax, 58, 629-631. [Google Scholar] [CrossRef] [PubMed]
[35] 查震球. 慢性阻塞性肺疾病流行病学研究进展[J]. 安徽预防医学杂志, 2022, 28(3): 171-176.
[36] Zhou, M., Wang, H., Zeng, X., Yin, P., Zhu, J., Chen, W., et al. (2019) Mortality, Morbidity, and Risk Factors in China and Its Provinces, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017. The Lancet, 394, 1145-1158. [Google Scholar] [CrossRef] [PubMed]
[37] Wang, C., Xu, J., Yang, L., Xu, Y., Zhang, X., Bai, C., et al. (2018) Prevalence and Risk Factors of Chronic Obstructive Pulmonary Disease in China (The China Pulmonary Health [CPH] Study): A National Cross-Sectional Study. The Lancet, 391, 1706-1717. [Google Scholar] [CrossRef] [PubMed]
[38] Fang, L., Gao, P., Bao, H., Tang, X., Wang, B., Feng, Y., et al. (2018) Chronic Obstructive Pulmonary Disease in China: A Nationwide Prevalence Study. The Lancet Respiratory Medicine, 6, 421-430. [Google Scholar] [CrossRef] [PubMed]
[39] Paulin, P., Maritano Furcada, J., Ungaro, C.M., Bendelman, G., Waisman, G.D., Castro, H.M., et al. (2017) Effect of Angiotensin 2 Receptor Blockers on Chronic Obstructive Lung Disease Mortality: A Retrospective Cohort Study. Pulmonary Pharmacology & Therapeutics, 44, 78-82. [Google Scholar] [CrossRef] [PubMed]
[40] Qaisar, R., Kamli, H., Karim, A., Muhammad, T., Ahmad, F. and Shaikh, A. (2023) Angiotensin Receptor Blockers Restore Skeletal Muscle in Patients with Chronic Obstructive Pulmonary Disease. Archives of Medical Research, 54, Article 102890. [Google Scholar] [CrossRef] [PubMed]

为你推荐